Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1423812

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1423812

Breast Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 353 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

Advancements in Diagnosis and Treatment Drive Growth in Breast Biopsy Market

Increasing Prevalence of Breast Cancer and Growing Demand for Minimally-Invasive Techniques

In today's world, lifestyle factors and behavioral patterns play a significant role in the worsening of breast cancer. With obesity linked to higher insulin levels, the correlation between lifestyle choices and cancer risk is becoming clearer. Consequently, the demand for breast biopsy procedures, essential for confirming cancerous lesions, is on the rise.

According to statistics from the National Breast Cancer Foundation (2022), the United States alone witnesses a staggering number of breast cancer diagnoses, with a woman diagnosed approximately every 2 minutes. Moreover, the incidence of invasive breast cancer in 2022 reached nearly 287,500 cases, with 43,550 resulting in fatalities.

One key driver of the increased demand for breast biopsy procedures is the emphasis on early detection and screening programs. Regular mammography screenings and heightened awareness campaigns have led to the identification of breast abnormalities at earlier stages, necessitating further evaluation through biopsies.

The shift towards minimally invasive biopsy techniques, such as core needle biopsy and vacuum-assisted biopsy, has gained momentum due to their accuracy, reduced discomfort, and faster recovery times. As a result, the prevalence of breast cancer directly impacts the demand for biopsy procedures, prompting ongoing research and development efforts to enhance techniques and technologies.

Factors Contributing to the Demand Growth for Breast Biopsy Procedures

The demand for breast biopsy procedures is bolstered by the increasing prevalence of breast cancer globally. As companies focus on technological advancements, opportunities arise for the development of more precise biopsy devices and companion diagnostic tools. Moreover, the trend towards personalized medicine presents avenues for targeted therapies and individualized treatment approaches.

Hindrances to the Adoption of Breast Biopsy

Despite the increasing demand, barriers to adoption persist. The high cost of equipment and lack of infrastructure pose challenges, particularly in regions with financial constraints. Additionally, regulatory complexities and reimbursement policies vary, impacting the accessibility of advanced biopsy techniques.

Country-wise Insights

  • United States: With advanced diagnostic methods and favorable reimbursement practices, the U.S. remains a lucrative market for breast biopsy equipment manufacturers.
  • China: Increasing government investments in healthcare infrastructure drive growth opportunities, supported by technological advancements and awareness initiatives.
  • United Kingdom: Strong research and innovation contribute to the development of new biopsy technologies, with emphasis on early detection and treatment awareness.

Category-wise Insights

  • Breast Biopsy Needles: Cost-effectiveness and ease of use drive high sales in this segment, constituting a significant portion of the global market.
  • Indications: The increasing utilization of breast biopsy equipment for diagnosing complex cysts occupies a leading share of the market.

Competitive Analysis

Key manufacturers continue to innovate, launching novel products to detect breast cancer. Mergers and acquisitions remain strategic avenues for established players to strengthen their market position.

Key Companies Covered

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Key Segments of Breast Biopsy Industry

Product:

  • Biopsy Needles
    • Core Needles
    • Fine Aspiration Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
    • Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Breast Biopsy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2018 - 2023

  • 3.1. Global Average Price Analysis, by Product/ Indication, US$ Per Unit, 2018 - 2023
  • 3.2. Prominent Factor Affecting Breast Tissue Markers Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Breast Biopsy Market Outlook, 2018 - 2031

  • 4.1. Global Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Biopsy Needles
        • 4.1.1.1.1. Core Needles
        • 4.1.1.1.2. Fine Aspiration Needles
      • 4.1.1.2. MRI-Guide Biopsy Systems
      • 4.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 4.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 4.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 4.1.1.4. Vacuum-Assisted Devices (VAD)
      • 4.1.1.5. Guide Wire (Localization Wire)
      • 4.1.1.6. Breast Biopsy Markers
  • 4.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Complex Cysts
      • 4.2.1.2. Solid Mass
      • 4.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 4.2.1.4. Suspicious Micro-calcifications
  • 4.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Ambulatory Surgical Centers
      • 4.3.1.4. Cancer Research Institutes
  • 4.4. Global Breast Biopsy Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Breast Biopsy Market Outlook, 2018 - 2031

  • 5.1. North America Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Biopsy Needles
        • 5.1.1.1.1. Core Needles
        • 5.1.1.1.2. Fine Aspiration Needles
      • 5.1.1.2. MRI-Guide Biopsy Systems
      • 5.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 5.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 5.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 5.1.1.4. Vacuum-Assisted Devices (VAD)
      • 5.1.1.5. Guide Wire (Localization Wire)
      • 5.1.1.6. Breast Biopsy Markers
  • 5.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Complex Cysts
      • 5.2.1.2. Solid Mass
      • 5.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 5.2.1.4. Suspicious Micro-calcifications
  • 5.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Ambulatory Surgical Centers
      • 5.3.1.4. Cancer Research Institutes
  • 5.4. North America Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.4.1.2. U.S. Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.4.1.3. U.S. Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.4.1.4. Canada Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.4.1.5. Canada Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.4.1.6. Canada Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Breast Biopsy Market Outlook, 2018 - 2031

  • 6.1. Europe Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Biopsy Needles
        • 6.1.1.1.1. Core Needles
        • 6.1.1.1.2. Fine Aspiration Needles
      • 6.1.1.2. MRI-Guide Biopsy Systems
      • 6.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 6.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 6.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 6.1.1.4. Vacuum-Assisted Devices (VAD)
      • 6.1.1.5. Guide Wire (Localization Wire)
      • 6.1.1.6. Breast Biopsy Markers
  • 6.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Complex Cysts
      • 6.2.1.2. Solid Mass
      • 6.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 6.2.1.4. Suspicious Micro-calcifications
  • 6.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Ambulatory Surgical Centers
      • 6.3.1.4. Cancer Research Institutes
  • 6.4. Europe Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.2. Germany Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.3. Germany Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.4. U.K. Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.5. U.K. Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.6. U.K. Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.7. France Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.8. France Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.9. France Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.10. Italy Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.11. Italy Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.12. Italy Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.13. Turkey Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.14. Turkey Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.15. Turkey Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.16. Russia Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.17. Russia Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.18. Russia Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.19. Rest of Europe Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.20. Rest of Europe Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.21. Rest of Europe Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Breast Biopsy Market Outlook, 2018 - 2031

  • 7.1. Asia Pacific Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Biopsy Needles
        • 7.1.1.1.1. Core Needles
        • 7.1.1.1.2. Fine Aspiration Needles
      • 7.1.1.2. MRI-Guide Biopsy Systems
      • 7.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 7.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 7.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 7.1.1.4. Vacuum-Assisted Devices (VAD)
      • 7.1.1.5. Guide Wire (Localization Wire)
      • 7.1.1.6. Breast Biopsy Markers
  • 7.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Complex Cysts
      • 7.2.1.2. Solid Mass
      • 7.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 7.2.1.4. Suspicious Micro-calcifications
  • 7.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Ambulatory Surgical Centers
      • 7.3.1.4. Cancer Research Institutes
  • 7.4. Asia Pacific Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.2. China Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.3. China Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.4. Japan Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.5. Japan Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.6. Japan Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.7. South Korea Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.8. South Korea Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.9. South Korea Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.10. India Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.11. India Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.12. India Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.13. Southeast Asia Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.14. Southeast Asia Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.15. Southeast Asia Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.16. Rest of Asia Pacific Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.17. Rest of Asia Pacific Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.18. Rest of Asia Pacific Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Breast Biopsy Market Outlook, 2018 - 2031

  • 8.1. Latin America Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Biopsy Needles
        • 8.1.1.1.1. Core Needles
        • 8.1.1.1.2. Fine Aspiration Needles
      • 8.1.1.2. MRI-Guide Biopsy Systems
      • 8.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 8.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 8.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 8.1.1.4. Vacuum-Assisted Devices (VAD)
      • 8.1.1.5. Guide Wire (Localization Wire)
      • 8.1.1.6. Breast Biopsy Markers
  • 8.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Complex Cysts
      • 8.2.1.2. Solid Mass
      • 8.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 8.2.1.4. Suspicious Micro-calcifications
  • 8.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Ambulatory Surgical Centers
      • 8.3.1.4. Cancer Research Institutes
  • 8.4. Latin America Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.2. Brazil Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.3. Brazil Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.4. Mexico Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.5. Mexico Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.6. Mexico Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.7. Argentina Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.8. Argentina Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.9. Argentina Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.10. Rest of Latin America Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.11. Rest of Latin America Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.12. Rest of Latin America Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Breast Biopsy Market Outlook, 2018 - 2031

  • 9.1. Middle East & Africa Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Biopsy Needles
        • 9.1.1.1.1. Core Needles
        • 9.1.1.1.2. Fine Aspiration Needles
      • 9.1.1.2. MRI-Guide Biopsy Systems
      • 9.1.1.3. Ultrasound Guided Breast Biopsy Systems
        • 9.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 9.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 9.1.1.4. Vacuum-Assisted Devices (VAD)
      • 9.1.1.5. Guide Wire (Localization Wire)
      • 9.1.1.6. Breast Biopsy Markers
  • 9.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Complex Cysts
      • 9.2.1.2. Solid Mass
      • 9.2.1.3. Suspicious Solid Mass (Fibroadenoma)
      • 9.2.1.4. Suspicious Micro-calcifications
  • 9.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Specialty Clinics
      • 9.3.1.3. Ambulatory Surgical Centers
      • 9.3.1.4. Cancer Research Institutes
  • 9.4. Middle East & Africa Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.2. GCC Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.3. GCC Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.4. South Africa Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.5. South Africa Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.6. South Africa Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.7. Egypt Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.8. Egypt Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.9. Egypt Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.10. Nigeria Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.11. Nigeria Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.12. Nigeria Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.13. Rest of Middle East & Africa Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.14. Rest of Middle East & Africa Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.15. Rest of Middle East & Africa Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Product vs Indication Heatmap
  • 10.2. Company Market Share Analysis, 2023
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Argon Medical
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Becton Dickinson and Company
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. C.R. Bard, Inc.
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Cook Medical Inc.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Devicor Medical Products, Inc.
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. F. Hoffmann-La Roche Ltd.,
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. GE Healthcare
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Hologic, Inc.
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Leica Biosystems
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Medax Srl Unipersonale
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Planmed Oy
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Scion Medical Technologies, LLC
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development
    • 10.4.13. Siemens Healthineers
      • 10.4.13.1. Company Overview
      • 10.4.13.2. Product Portfolio
      • 10.4.13.3. Financial Overview
      • 10.4.13.4. Business Strategies and Development
    • 10.4.14. Hikma Pharmaceuticals
      • 10.4.14.1. Company Overview
      • 10.4.14.2. Product Portfolio
      • 10.4.14.3. Financial Overview
      • 10.4.14.4. Business Strategies and Development
    • 10.4.15. Incytes
      • 10.4.15.1. Company Overview
      • 10.4.15.2. Product Portfolio
      • 10.4.15.3. Financial Overview
      • 10.4.15.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!